LONDON - Duke University Medical Center scientists have discovered the first genetic marker that predicts response to hepatitis C treatments.
Archive for the 'Health' Category
Gene variant predicts hepatitis treatment success
NEW YORK — Scientists say they’ve found a big reason why treatment for chronic hepatitis C infection works better for white patients than for African-Americans. It’s a tiny variation in a gene.
WASHINGTON - Experts at Heidelberg University Hospital in Germany say that they have identified a protein in infected liver cells that is essential for the replication of the hepatitis C virus (HCV).
LONDON - Some kinds of influenza viruses may set up people infected with them to be at higher risk of developing chronic neurodegenerative diseases like Parkinson’s and Alzheimer’s later in life, according to a new study.
NEW DELHI - Medicinal herbs like tulsi, which is commonly found in people’s homes, can help boost one’s immunity and thus fight Influenza A (H1N1), say Ayurveda doctors.
Anadys says hepatitis C drug shows potential
SAN DIEGO — Anadys Pharmaceuticals Inc. said Tuesday its hepatitis C drug candidate ANA-773 could be extremely effective at treating the diseases.
WASHINGTON - Blueberry leaves might offer protection against hepatitis C virus infections, according to researchers.
WASHINGTON - A volunteer has for the first time received a human monoclonal antibody that can neutralize the Hepatitis C virus (HCV).
New HIV strain discovered in woman from Cameroon
WASHINGTON — A new strain of the virus that causes AIDS has been discovered in a woman from the African nation of Cameroon.
Anadys rockets after FDA approves trial design
NEW YORK — Shares of Anadys Pharmaceuticals Inc. climbed Friday after the company said regulators approved the design of a study of a potential hepatitis C treatment.